Advertisement

Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Document › Details

Evotec AG. (3/28/17). "Press Release: Evotec Fiscal Year Results 2016. Leading Innovation Efficiency and First-in-class Drug Discovery". Hamburg.

Organisations Organisation Evotec AG (FSE: EVT, TecDAX)
  Today Evotec SE (FSE: EVT, MDA X/TecDAX)
  Group Evotec (Group)
  Organisation 2 Topas Therapeutics GmbH
Products Product drug discovery services
  Product 2 EVT 201
Index terms Index term Cyprotex–Evotec: investment, 201610–201612 acquisition £55.7m=€66.3m in cash for all 26.1m shares + funding of all debt
  Index term 2 Evotec–Novo Group: investment, 201702 strategic investment of €90.3m 13.15m new Evotec shares at €6.87/share resulting in 8.9% ownership by Novo A/S
     


   
Record changed: 2017-04-19

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Evotec (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top